Itafos (IFOS) Q1 2025 earnings summary

Executive summary

• Revenues increased 6% year-over-year to $135.7M, driven by higher SPA prices and sales at Conda and increased sulfuric acid and dry product sales at Arraias.

• Net income rose 51% year-over-year to $35.9M, primarily due to a $27.9M gain on the sale of the Araxá project and lower finance expenses, partially offset by higher taxes.

• Adjusted EBITDA was $39.3M, down 9% year-over-year, reflecting higher input costs at Conda and increased growth capex.

• Free cash flow surged 77% to $31.3M, supported by higher operating cash flows and proceeds from the Araxá sale.

• A C$0.05/share special dividend was declared and paid in April 2025.

Financial highlights

• Gross margin declined 14% year-over-year to $34.0M due to higher input costs, especially sulfur at Conda.

• Basic EPS was $0.19 (C$0.27), up 58% year-over-year.

• Total assets grew 6% to $738.5M, and total equity increased 9% to $377.8M as of March 31, 2025.

• Net debt improved to $(1.7)M from $26.8M at year-end, reflecting higher cash balances.

• Net leverage ratio improved to (0.0)x from 0.2x at year-end.

Outlook and guidance

• 2025 guidance maintained: sales volumes of 340–360k tonnes P2O5, corporate SG&A $17–20M, maintenance capex $13–23M, growth capex $63–83M, and environmental/ARO payments $5–7M.

• Phosphate pricing expected to remain strong through 2025, supported by global demand, limited US imports, and Chinese export restrictions.

• Focus remains on operational improvements, H1/NDR mine development, and prudent capital returns.